Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 93 entries
Sorted by: Best Match Show Resources per page
Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.

PloS one

Chitnis CE, Mukherjee P, Mehta S, Yazdani SS, Dhawan S, Shakri AR, Bhardwaj R, Gupta PK, Hans D, Mazumdar S, Singh B, Kumar S, Pandey G, Parulekar V, Imbault N, Shivyogi P, Godbole G, Mohan K, Leroy O, Singh K, Chauhan VS.
PMID: 26332825
PLoS One. 2015 Sep 02;10(9):e0137816. doi: 10.1371/journal.pone.0137816. eCollection 2015.

[This corrects the article DOI: 10.1371/journal.pone.0117820.].

Cite
Chitnis CE, Mukherjee P, Mehta S, et al. Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175. PLoS One. 2015;10(9):e0137816doi: 10.1371/journal.pone.0137816.
Chitnis, C. E., Mukherjee, P., Mehta, S., Yazdani, S. S., Dhawan, S., Shakri, A. R., Bhardwaj, R., Gupta, P. K., Hans, D., Mazumdar, S., Singh, B., Kumar, S., Pandey, G., Parulekar, V., Imbault, N., Shivyogi, P., Godbole, G., Mohan, K., Leroy, O., Singh, K., & Chauhan, V. S. (2015). Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175. PloS one, 10(9), e0137816. https://doi.org/10.1371/journal.pone.0137816
Chitnis, Chetan E, et al. "Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175." PloS one vol. 10,9 (2015): e0137816. doi: https://doi.org/10.1371/journal.pone.0137816
Chitnis CE, Mukherjee P, Mehta S, Yazdani SS, Dhawan S, Shakri AR, Bhardwaj R, Gupta PK, Hans D, Mazumdar S, Singh B, Kumar S, Pandey G, Parulekar V, Imbault N, Shivyogi P, Godbole G, Mohan K, Leroy O, Singh K, Chauhan VS. Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175. PLoS One. 2015 Sep 02;10(9):e0137816. doi: 10.1371/journal.pone.0137816. eCollection 2015. PMID: 26332825; PMCID: PMC4558041.
Copy Download .nbib Format: NLM
A detailed phenotypic analysis of immune cell populations in the bronchoalveolar lavage fluid of atopic asthmatics after segmental allergen challenge.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Boomer JS, Parulekar AD, Patterson BM, Yin-Declue H, Deppong CM, Crockford S, Jarjour NN, Castro M, Green JM.
PMID: 24330650
Allergy Asthma Clin Immunol. 2013 Sep 17;9(1):37. doi: 10.1186/1710-1492-9-37.

BACKGROUND: Atopic asthma is characterized by intermittent exacerbations triggered by exposure to allergen. Exacerbations are characterized by an acute inflammatory reaction in the airways, with recruitment of both innate and adaptive immune cells. These cell populations as well as...

Cite
Boomer JS, Parulekar AD, Patterson BM, et al. A detailed phenotypic analysis of immune cell populations in the bronchoalveolar lavage fluid of atopic asthmatics after segmental allergen challenge. Allergy Asthma Clin Immunol. 2013;9(1):37doi: 10.1186/1710-1492-9-37.
Boomer, J. S., Parulekar, A. D., Patterson, B. M., Yin-Declue, H., Deppong, C. M., Crockford, S., Jarjour, N. N., Castro, M., & Green, J. M. (2013). A detailed phenotypic analysis of immune cell populations in the bronchoalveolar lavage fluid of atopic asthmatics after segmental allergen challenge. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 9(1), 37. https://doi.org/10.1186/1710-1492-9-37
Boomer, Jonathan S, et al. "A detailed phenotypic analysis of immune cell populations in the bronchoalveolar lavage fluid of atopic asthmatics after segmental allergen challenge." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 9,1 (2013): 37. doi: https://doi.org/10.1186/1710-1492-9-37
Boomer JS, Parulekar AD, Patterson BM, Yin-Declue H, Deppong CM, Crockford S, Jarjour NN, Castro M, Green JM. A detailed phenotypic analysis of immune cell populations in the bronchoalveolar lavage fluid of atopic asthmatics after segmental allergen challenge. Allergy Asthma Clin Immunol. 2013 Sep 17;9(1):37. doi: 10.1186/1710-1492-9-37. PMID: 24330650; PMCID: PMC3848528.
Copy Download .nbib Format: NLM
Cell growth and alpha-amylase production characteristics of Bacillus amyloliquefaciens.

Biotechnology and bioengineering

Roychoudhury S, Parulekar SJ, Weigand WA.
PMID: 18587901
Biotechnol Bioeng. 1989 Jan 10;33(2):197-206. doi: 10.1002/bit.260330209.

Growth and alpha-amylase production characteristics of Bacillus amyloliquefaciens strain F (ATCC 23350) in batch cultures are examined using glucose or maltose as the carbon source. While the cell growth is rapid when glucose is used as the carbon source,...

Cite
Roychoudhury S, Parulekar SJ, Weigand WA. Cell growth and alpha-amylase production characteristics of Bacillus amyloliquefaciens. Biotechnol Bioeng. 1989;33(2):197-206doi: 10.1002/bit.260330209.
Roychoudhury, S., Parulekar, S. J., & Weigand, W. A. (1989). Cell growth and alpha-amylase production characteristics of Bacillus amyloliquefaciens. Biotechnology and bioengineering, 33(2), 197-206. https://doi.org/10.1002/bit.260330209
Roychoudhury, S, et al. "Cell growth and alpha-amylase production characteristics of Bacillus amyloliquefaciens." Biotechnology and bioengineering vol. 33,2 (1989): 197-206. doi: https://doi.org/10.1002/bit.260330209
Roychoudhury S, Parulekar SJ, Weigand WA. Cell growth and alpha-amylase production characteristics of Bacillus amyloliquefaciens. Biotechnol Bioeng. 1989 Jan 10;33(2):197-206. doi: 10.1002/bit.260330209. PMID: 18587901.
Copy Download .nbib Format: NLM
Analysis of continuous cultures of recombinant methylotrophs.

Biotechnology and bioengineering

Parulekar SJ, Chang YK, Modak JM, Lim HC.
PMID: 18576540
Biotechnol Bioeng. 1987 Jun;29(8):911-23. doi: 10.1002/bit.260290802.

Static and dynamic characteristics of continuous cultures of recombinant methylotrophs, which are designed to improve the selectivity of plasmid-bearing cells and the plasmid stability, are investigated in detail. Operational regions in which coexistence (survival of plasmid-bearing and plasmid-free cells)...

Cite
Parulekar SJ, Chang YK, Modak JM, et al. Analysis of continuous cultures of recombinant methylotrophs. Biotechnol Bioeng. 1987;29(8):911-23doi: 10.1002/bit.260290802.
Parulekar, S. J., Chang, Y. K., Modak, J. M., & Lim, H. C. (1987). Analysis of continuous cultures of recombinant methylotrophs. Biotechnology and bioengineering, 29(8), 911-23. https://doi.org/10.1002/bit.260290802
Parulekar, S J, et al. "Analysis of continuous cultures of recombinant methylotrophs." Biotechnology and bioengineering vol. 29,8 (1987): 911-23. doi: https://doi.org/10.1002/bit.260290802
Parulekar SJ, Chang YK, Modak JM, Lim HC. Analysis of continuous cultures of recombinant methylotrophs. Biotechnol Bioeng. 1987 Jun;29(8):911-23. doi: 10.1002/bit.260290802. PMID: 18576540.
Copy Download .nbib Format: NLM
Induction and elimination of oscillations in continuous cultures of Saccharomyces cerevisiae.

Biotechnology and bioengineering

Parulekar SJ, Semones GB, Rolf MJ, Lievense JC, Lim HC.
PMID: 18555381
Biotechnol Bioeng. 1986 May;28(5):700-10. doi: 10.1002/bit.260280509.

Continuous cultures of Saccharomyces cerevisiae are known to exhibit oscillatory behavior in the oxidative region. Important findings of a series of experiments conducted to identify the causes for initiation of and the means for elimination of oscillations in these...

Cite
Parulekar SJ, Semones GB, Rolf MJ, et al. Induction and elimination of oscillations in continuous cultures of Saccharomyces cerevisiae. Biotechnol Bioeng. 1986;28(5):700-10doi: 10.1002/bit.260280509.
Parulekar, S. J., Semones, G. B., Rolf, M. J., Lievense, J. C., & Lim, H. C. (1986). Induction and elimination of oscillations in continuous cultures of Saccharomyces cerevisiae. Biotechnology and bioengineering, 28(5), 700-10. https://doi.org/10.1002/bit.260280509
Parulekar, S J, et al. "Induction and elimination of oscillations in continuous cultures of Saccharomyces cerevisiae." Biotechnology and bioengineering vol. 28,5 (1986): 700-10. doi: https://doi.org/10.1002/bit.260280509
Parulekar SJ, Semones GB, Rolf MJ, Lievense JC, Lim HC. Induction and elimination of oscillations in continuous cultures of Saccharomyces cerevisiae. Biotechnol Bioeng. 1986 May;28(5):700-10. doi: 10.1002/bit.260280509. PMID: 18555381.
Copy Download .nbib Format: NLM
Health insurance: Is Indian rural population aware?.

International journal of applied & basic medical research

Pandve HT, Parulekar CV.
PMID: 24083151
Int J Appl Basic Med Res. 2013 Jul;3(2):132. doi: 10.4103/2229-516X.117100.

No abstract available.

Cite
Pandve HT, Parulekar CV. Health insurance: Is Indian rural population aware?. Int J Appl Basic Med Res. 2013;3(2):132doi: 10.4103/2229-516X.117100.
Pandve, H. T., & Parulekar, C. V. (2013). Health insurance: Is Indian rural population aware?. International journal of applied & basic medical research, 3(2), 132. https://doi.org/10.4103/2229-516X.117100
Pandve, Harshal T, and Parulekar, Chandrakant V. "Health insurance: Is Indian rural population aware?." International journal of applied & basic medical research vol. 3,2 (2013): 132. doi: https://doi.org/10.4103/2229-516X.117100
Pandve HT, Parulekar CV. Health insurance: Is Indian rural population aware?. Int J Appl Basic Med Res. 2013 Jul;3(2):132. doi: 10.4103/2229-516X.117100. PMID: 24083151; PMCID: PMC3783668.
Copy Download .nbib Format: NLM
Meningiomas in children: A study of 18 cases.

Journal of pediatric neurosciences

Mehta N, Bhagwati S, Parulekar G.
PMID: 21887184
J Pediatr Neurosci. 2009 Jul;4(2):61-5. doi: 10.4103/1817-1745.57322.

BACKGROUND: Intracranial meningiomas are rare tumors in children accounting for 0.4-4.6% of all primary brain tumors in the age group of 0-18 years.OBJECTIVE: To retrospectively analyze the epidemiological profile, clinical features, radiological findings, type of excision, histopathological findings, and...

Cite
Mehta N, Bhagwati S, Parulekar G. Meningiomas in children: A study of 18 cases. J Pediatr Neurosci. 2009;4(2):61-5doi: 10.4103/1817-1745.57322.
Mehta, N., Bhagwati, S., & Parulekar, G. (2009). Meningiomas in children: A study of 18 cases. Journal of pediatric neurosciences, 4(2), 61-5. https://doi.org/10.4103/1817-1745.57322
Mehta, Nirav, et al. "Meningiomas in children: A study of 18 cases." Journal of pediatric neurosciences vol. 4,2 (2009): 61-5. doi: https://doi.org/10.4103/1817-1745.57322
Mehta N, Bhagwati S, Parulekar G. Meningiomas in children: A study of 18 cases. J Pediatr Neurosci. 2009 Jul;4(2):61-5. doi: 10.4103/1817-1745.57322. PMID: 21887184; PMCID: PMC3162790.
Copy Download .nbib Format: NLM
Geriatric Consultation Reduces High-risk Medication Usage at Discharge in Elderly Trauma Patients.

Cureus

Sharma J, Parulekar M, Stewart P, Blatt M, Zielonka T, Nyirenda T, Rogers C, Tank L.
PMID: 30723648
Cureus. 2018 Nov 28;10(11):e3649. doi: 10.7759/cureus.3649.

Background Traumatic injury in a growing geriatric population is associated with higher mortality and complication rates. Geriatric consultation (GC) is vital in reducing risk factors that contribute to adverse outcomes. This study aims to determine if receiving a GC...

Cite
Sharma J, Parulekar M, Stewart P, et al. Geriatric Consultation Reduces High-risk Medication Usage at Discharge in Elderly Trauma Patients. Cureus. 2018;10(11):e3649doi: 10.7759/cureus.3649.
Sharma, J., Parulekar, M., Stewart, P., Blatt, M., Zielonka, T., Nyirenda, T., Rogers, C., & Tank, L. (2018). Geriatric Consultation Reduces High-risk Medication Usage at Discharge in Elderly Trauma Patients. Cureus, 10(11), e3649. https://doi.org/10.7759/cureus.3649
Sharma, Jyoti, et al. "Geriatric Consultation Reduces High-risk Medication Usage at Discharge in Elderly Trauma Patients." Cureus vol. 10,11 (2018): e3649. doi: https://doi.org/10.7759/cureus.3649
Sharma J, Parulekar M, Stewart P, Blatt M, Zielonka T, Nyirenda T, Rogers C, Tank L. Geriatric Consultation Reduces High-risk Medication Usage at Discharge in Elderly Trauma Patients. Cureus. 2018 Nov 28;10(11):e3649. doi: 10.7759/cureus.3649. PMID: 30723648; PMCID: PMC6351116.
Copy Download .nbib Format: NLM
Trache teams.

Journal of the Intensive Care Society

Parulekar P, Drage S.
PMID: 29456609
J Intensive Care Soc. 2018 Feb;19(1):83. doi: 10.1177/1751143717711356. Epub 2018 Feb 05.

No abstract available.

Cite
Parulekar P, Drage S. Trache teams. J Intensive Care Soc. 2018;19(1):83doi: 10.1177/1751143717711356.
Parulekar, P., & Drage, S. (2018). Trache teams. Journal of the Intensive Care Society, 19(1), 83. https://doi.org/10.1177/1751143717711356
Parulekar, Prashant, and Drage, Stephen. "Trache teams." Journal of the Intensive Care Society vol. 19,1 (2018): 83. doi: https://doi.org/10.1177/1751143717711356
Parulekar P, Drage S. Trache teams. J Intensive Care Soc. 2018 Feb;19(1):83. doi: 10.1177/1751143717711356. Epub 2018 Feb 05. PMID: 29456609; PMCID: PMC5810868.
Copy Download .nbib Format: NLM
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.

JNCI cancer spectrum

Dowling RJO, Sparano JA, Goodwin PJ, Bidard FC, Cescon DW, Chandarlapaty S, Deasy JO, Dowsett M, Gray RJ, Henry NL, Meric-Bernstam F, Perlmutter J, Sledge GW, Thorat MA, Bratman SV, Carey LA, Chang MC, DeMichele A, Ennis M, Jerzak KJ, Korde LA, Lohmann AE, Mamounas EP, Parulekar WR, Regan MM, Schramek D, Stambolic V, Whelan TJ, Wolff AC, Woodgett JR, Kalinsky K, Hayes DF.
PMID: 32337478
JNCI Cancer Spectr. 2019 Aug 10;3(4):pkz049. doi: 10.1093/jncics/pkz049. eCollection 2019 Dec.

Late disease recurrence (more than 5 years after initial diagnosis) represents a clinical challenge in the treatment and management of estrogen receptor-positive breast cancer (BC). An international workshop was convened in Toronto, Canada, in February 2018 to review the...

Cite
Dowling RJO, Sparano JA, Goodwin PJ, et al. Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions. JNCI Cancer Spectr. 2019;3(4):pkz049doi: 10.1093/jncics/pkz049.
Dowling, R. J. O., Sparano, J. A., Goodwin, P. J., Bidard, F. C., Cescon, D. W., Chandarlapaty, S., Deasy, J. O., Dowsett, M., Gray, R. J., Henry, N. L., Meric-Bernstam, F., Perlmutter, J., Sledge, G. W., Thorat, M. A., Bratman, S. V., Carey, L. A., Chang, M. C., DeMichele, A., Ennis, M., Jerzak, K. J., Korde, L. A., Lohmann, A. E., Mamounas, E. P., Parulekar, W. R., Regan, M. M., Schramek, D., Stambolic, V., Whelan, T. J., Wolff, A. C., Woodgett, J. R., Kalinsky, K., & Hayes, D. F. (2019). Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions. JNCI cancer spectrum, 3(4), pkz049. https://doi.org/10.1093/jncics/pkz049
Dowling, Ryan J O, et al. "Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions." JNCI cancer spectrum vol. 3,4 (2019): pkz049. doi: https://doi.org/10.1093/jncics/pkz049
Dowling RJO, Sparano JA, Goodwin PJ, Bidard FC, Cescon DW, Chandarlapaty S, Deasy JO, Dowsett M, Gray RJ, Henry NL, Meric-Bernstam F, Perlmutter J, Sledge GW, Thorat MA, Bratman SV, Carey LA, Chang MC, DeMichele A, Ennis M, Jerzak KJ, Korde LA, Lohmann AE, Mamounas EP, Parulekar WR, Regan MM, Schramek D, Stambolic V, Whelan TJ, Wolff AC, Woodgett JR, Kalinsky K, Hayes DF. Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions. JNCI Cancer Spectr. 2019 Aug 10;3(4):pkz049. doi: 10.1093/jncics/pkz049. eCollection 2019 Dec. PMID: 32337478; PMCID: PMC7050024.
Copy Download .nbib Format: NLM
Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT).

JAMA oncology

Ramaswamy A, Ostwal V, Sharma A, Bhargava P, Srinivas S, Goel M, Patkar S, Mandavkar S, Jadhav P, Parulekar M, Choudhari A, Gupta S.
PMID: 33270098
JAMA Oncol. 2021 Mar 01;7(3):436-439. doi: 10.1001/jamaoncol.2020.6166.

IMPORTANCE: There is therapeutic uncertainty regarding use of combination or single-agent chemotherapy in the treatment of patients with gallbladder cancer who experience disease progression after first-line chemotherapy.OBJECTIVE: To compare the efficacy of capecitabine plus irinotecan (CAPIRI) vs irinotecan (IRI)...

Cite
Ramaswamy A, Ostwal V, Sharma A, et al. Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT). JAMA Oncol. 2021;7(3):436-439doi: 10.1001/jamaoncol.2020.6166.
Ramaswamy, A., Ostwal, V., Sharma, A., Bhargava, P., Srinivas, S., Goel, M., Patkar, S., Mandavkar, S., Jadhav, P., Parulekar, M., Choudhari, A., & Gupta, S. (2021). Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT). JAMA oncology, 7(3), 436-439. https://doi.org/10.1001/jamaoncol.2020.6166
Ramaswamy, Anant, et al. "Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)." JAMA oncology vol. 7,3 (2021): 436-439. doi: https://doi.org/10.1001/jamaoncol.2020.6166
Ramaswamy A, Ostwal V, Sharma A, Bhargava P, Srinivas S, Goel M, Patkar S, Mandavkar S, Jadhav P, Parulekar M, Choudhari A, Gupta S. Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT). JAMA Oncol. 2021 Mar 01;7(3):436-439. doi: 10.1001/jamaoncol.2020.6166. PMID: 33270098; PMCID: PMC7716253.
Copy Download .nbib Format: NLM
Furthering the One Health Mission:: Template for Establishing Student-Run One Health Groups on College Campuses.

Delaware journal of public health

Fitzgerald H, Parulekar M, Schach E, Bachmann G.
PMID: 34467174
Dela J Public Health. 2021 Jan 21;7(1):8-10. doi: 10.32481/djph.2021.01.004. eCollection 2021 Jan.

INTRODUCTION: Although it has been well-established that animal health and environmental health impact human health, there is a lack of inclusion of One Health in the education of medical and undergraduate studentsRATIONALE: Due to the fundamental lack of One...

Cite
Fitzgerald H, Parulekar M, Schach E, et al. Furthering the One Health Mission:: Template for Establishing Student-Run One Health Groups on College Campuses. Dela J Public Health. 2021;7(1):8-10doi: 10.32481/djph.2021.01.004.
Fitzgerald, H., Parulekar, M., Schach, E., Bachmann, G. (2021). Furthering the One Health Mission:: Template for Establishing Student-Run One Health Groups on College Campuses. Delaware journal of public health, 7(1), 8-10. https://doi.org/10.32481/djph.2021.01.004
Fitzgerald, Halle, et al. "Furthering the One Health Mission:: Template for Establishing Student-Run One Health Groups on College Campuses." Delaware journal of public health vol. 7,1 (2021): 8-10. doi: https://doi.org/10.32481/djph.2021.01.004
Fitzgerald H, Parulekar M, Schach E, Bachmann G. Furthering the One Health Mission:: Template for Establishing Student-Run One Health Groups on College Campuses. Dela J Public Health. 2021 Jan 21;7(1):8-10. doi: 10.32481/djph.2021.01.004. eCollection 2021 Jan. PMID: 34467174; PMCID: PMC8352537.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 93 entries